Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Intuitive Surgical Stock (ISRG) Opinions on Q3 Earnings Beat

None

Earnings Surge: Intuitive Surgical (ISRG) has generated significant buzz on X following its third-quarter earnings report, which showcased a remarkable revenue increase and a 20% rise in global da Vinci procedures. Many discussions highlight the company’s raised full-year guidance for 2025, fueling excitement about sustained growth. Posts on the platform reflect a strong focus on the stock’s impressive 19.5% gain last month.

Innovation Focus: Conversations on X also center on ISRG’s leadership in robotic-assisted surgery, with users pointing to the da Vinci system’s adoption as a key driver of future potential. There’s notable interest in how the company’s innovations continue to shape the healthcare sector. The chatter underscores confidence in its long-term compounding growth, with some referencing historical returns over decades.

Note: This discussion summary was generated from an AI condensation of post data.

Intuitive Surgical Insider Trading Activity

ISRG Insider Trades

Intuitive Surgical insiders have traded $ISRG stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by insiders over the last 6 months:

  • GARY S GUTHART (Executive Chair of the Board o) has made 0 purchases and 7 sales selling 71,653 shares for an estimated $36,493,837.
  • DAVID J. ROSA (Chief Executive Officer (CEO)) sold 24,500 shares for an estimated $13,414,979
  • MYRIAM CURET (EVP & Chief Medical Officer) has made 0 purchases and 5 sales selling 12,187 shares for an estimated $6,431,227.
  • CRAIG H BARRATT sold 2,193 shares for an estimated $1,201,785
  • MARK BROSIUS (SVP & Chief Mfg and Supply Cha) has made 0 purchases and 10 sales selling 1,184 shares for an estimated $657,803.
  • AMY L LADD has made 0 purchases and 2 sales selling 671 shares for an estimated $305,588.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Intuitive Surgical Congressional Stock Trading

Members of Congress have traded $ISRG stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Intuitive Surgical Hedge Fund Activity

We have seen 1,063 institutional investors add shares of Intuitive Surgical stock to their portfolio, and 994 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Intuitive Surgical Government Contracts

We have seen $20,584,665 of award payments to $ISRG over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Intuitive Surgical Analyst Ratings

Wall Street analysts have issued reports on $ISRG in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Wells Fargo issued a "Overweight" rating on 10/22/2025
  • Piper Sandler issued a "Overweight" rating on 10/22/2025
  • BTIG issued a "Buy" rating on 10/22/2025
  • RBC Capital issued a "Outperform" rating on 10/22/2025
  • Raymond James issued a "Outperform" rating on 10/22/2025
  • Truist Securities issued a "Buy" rating on 10/22/2025
  • Deutsche Bank issued a "Sell" rating on 06/09/2025

To track analyst ratings and price targets for Intuitive Surgical, check out Quiver Quantitative's $ISRG forecast page.

Intuitive Surgical Price Targets

Multiple analysts have issued price targets for $ISRG recently. We have seen 10 analysts offer price targets for $ISRG in the last 6 months, with a median target of $601.5.

Here are some recent targets:

  • Danielle Antalffy from UBS set a target price of $600.0 on 10/23/2025
  • Shagun Singh from RBC Capital set a target price of $625.0 on 10/22/2025
  • Larry Biegelsen from Wells Fargo set a target price of $600.0 on 10/22/2025
  • Jayson Bedford from Raymond James set a target price of $603.0 on 10/22/2025
  • Adam Maeder from Piper Sandler set a target price of $610.0 on 10/22/2025
  • Richard Newitter from Truist Securities set a target price of $620.0 on 10/22/2025
  • Ryan Zimmerman from BTIG set a target price of $589.0 on 10/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles